CytoPherx's Series A Round

CytoPherx raised a round of funding on October 22, 2007. Investors include Dow Employees Pension Plan.

CytoPherx, formerly Nephrion, is a clinical stage medical device company addressing inflammation based diseases and conditions with a selective cytopheresis-based inflammation modulating system.…

Articles about CytoPherx's Series A Round: